Inpixon Reports 2022 Financial Results and Provides Business Update
Inpixon Reports 21% Growth in Revenue to
Conference Call to be Held Today at
"We completed 2022 with a 21% increase in revenue. We also implemented initiatives to reduce our operating expenses and overhead costs and remain actively committed to pursuing meaningful opportunities that will provide our shareholders with additional value," commented
"Over the years, we have developed expertise in advanced technologies which allows us to support the digital transformation underway in many industries. Our full-stack industrial RTLS allows customers to locate, learn, and leverage business and operational intelligence to reduce costs, grow revenue, and increase productivity. This is done by creating a connected, visible, and automated industrial workflow with our industrial IoT (IIoT) platform, location-aware sensors, digital twins and advanced applications, which are scalable, flexible, and intelligent. Given our ability to address a wide variety of important use cases, we have secured new customers and numerous purchase orders during the year. We believe the breath of our software and hardware products that make up our RTLS solution sets us apart from others in the market. We believe we are at the forefront of this industry and well positioned to take advantage of the vast opportunities. We look forward to achieving additional milestones in 2023 for our RTLS business."
Business Highlights
- Completed distribution of workplace experience app business and business combination with
CXApp Inc. (formerly KINS Technology Group Inc.). - Named Leader in 2023 Gartner® Magic Quadrant™ for Indoor Location Services.
- Secured a purchase order valued at over
$1 million forInpixon's RTLS products from a leading transportation and industrial equipment provider. - Announced a collaboration agreement with Schauenburg Systems, an original-equipment manufacturer of mine safety systems and equipment, to sell
Inpixon's real-time location technologies. - Achieved FCC, ISED Certifications and established CE status for Inpixon Swarm Chirp V3.
- Joined SAP® Partner Program, offering location intelligence for advanced RTLS-enabled industrial automation.
Financial Results
Revenues for the year ended
Non-GAAP Adjusted EBITDA for the year ended
Proforma non-GAAP net loss per basic and diluted common share for the year ended
These financial results for 2022 are based on information available to management as of the date of this press release, and may be subject to further changes upon completion of the Company's quarterly and year-end operational and financial closing procedures.
Conference Call
The conference call will be available via telephone by dialing toll-free 888-506-0062 for
Investors and other interested parties are invited to submit questions to management prior to the call's start via email to [email protected].
A webcast replay will be available on the company's Investor Relations section of the website (ir.inpixon.com) through
[1] Gartner Magic Quadrant for Indoor Location Services,
Gartner Disclaimer
Gartner and Magic Quadrant are registered trademarks of Gartner, Inc. and/or its affiliates in the
About
Safe Harbor Statement
All statements in this release that are not based on historical fact are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 and the provisions of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. While management has based any forward-looking statements included in this release on its current expectations, the information on which such expectations were based may change. These forward-looking statements rely on a number of assumptions concerning future events and are subject to a number of risks, uncertainties and other factors, many of which are outside of the control of
Non-GAAP Financial Measures
Management believes that certain financial measures not in accordance with generally accepted accounting principles in
Management provides Adjusted EBITDA and pro forma net loss per share measures so that investors will have the same financial information that management uses, which may assist investors in assessing
For more information on our non-GAAP financial measures and a reconciliation of GAAP to non-GAAP measures, please see the "Reconciliation of Non-GAAP Financial Measures" table accompanying this press release.
Contacts
General inquiries:
Email: [email protected]
Web: inpixon.com/contact-us
Investor relations:
Tel: +1 212-671-1020
Email: [email protected]
INPIXON AND SUBSIDIARIES | ||||||
CONSOLIDATED BALANCE SHEETS | ||||||
(In thousands, except number of shares and par value data) | ||||||
As of | ||||||
|
| |||||
ASSETS | ||||||
Current Assets | ||||||
Cash and cash equivalents | $ | 20,235 | $ | 52,480 | ||
Accounts receivable, net of allowances of | 3,227 | 3,218 | ||||
Other receivables | 359 | 321 | ||||
Inventory, net | 2,442 | 1,976 | ||||
Short-term investments | - | 43,125 | ||||
Note receivable | 150 | - | ||||
Prepaid assets and other current assets | 3,453 | 4,842 | ||||
Total Current Assets | 29,866 | 105,962 | ||||
Property and equipment, net | 1,266 | 1,442 | ||||
Operating lease right-of-use asset, net | 1,212 | 1,736 | ||||
Software development costs, net | 1,752 | 1,792 | ||||
Investment in equity securities | 330 | 1,838 | ||||
Long-term investments | 716 | 2,500 | ||||
Intangible assets, net | 22,283 | 33,478 | ||||
Goodwill,net | - | 7,672 | ||||
Other assets | 210 | 253 | ||||
Total Assets | $ | 57,635 | $ | 156,673 | ||
LIABILITIES AND STOCKHOLDERS' EQUITY | ||||||
Current Liabilities | ||||||
Accounts payable | $ | 2,557 | $ | 2,414 | ||
Accrued liabilities | 4,355 | 10,665 | ||||
Operating lease obligation, current | 477 | 643 | ||||
Deferred revenue | 3,485 | 4,805 | ||||
Short-term debt | 13,643 | 3,490 | ||||
Acquisition liability | 197 | 5,114 | ||||
Total Current Liabilities | 24,714 | 27,131 | ||||
Long Term Liabilities | ||||||
Operating lease obligations, noncurrent | 778 | 1,108 | ||||
Other liabilities, noncurrent | 28 | 28 | ||||
Acquisition liability, noncurrent | -- | 220 | ||||
Total Liabilities | 25,520 | 28,487 | ||||
Commitments and Contingencies | -- | -- | ||||
Mezzanine Equity | ||||||
Series 7 Convertible Preferred Stock - 58,750 shares authorized; zero and 49,250 issued and outstanding as of | -- | 44,695 | ||||
Series 8 Convertible Preferred Stock - 53,197.7234 shares authorized; zero issued and outstanding as of | -- | -- | ||||
Stockholders' Equity | ||||||
Preferred Stock - | ||||||
Series 4 Convertible Preferred Stock - 10,415 shares authorized; 1 issued, and 1 outstanding as of | -- | -- | ||||
Series 5 Convertible Preferred Stock - 12,000 shares authorized; 126 issued, and 126 outstanding as of | -- | -- | ||||
Common Stock - | 4 | 2 | ||||
Additional paid-in capital | 346,668 | 332,761 | ||||
(695) | (695) | |||||
Accumulated other comprehensive income | 1,061 | 44 | ||||
Accumulated deficit | (314,841) | (250,309) | ||||
Stockholders' Equity Attributable to | 32,197 | 81,803 | ||||
Non-controlling interest | (82) | 1,688 | ||||
Total Stockholders' Equity | 32,115 | 83,491 | ||||
Total Liabilities, Mezzanine Equity and Stockholders' Equity | $ | 57,635 | $ | 156,673 | ||
INPIXON AND SUBSIDIARIES | ||||||
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS | ||||||
(In thousands, except per share data) | ||||||
For the Years Ended | ||||||
2022 | 2021 | |||||
Revenues | $ | 19,418 | $ | 15,995 | ||
Cost of Revenues | 5,489 | 4,374 | ||||
Gross Profit | 13,929 | 11,621 | ||||
Operating Expenses | ||||||
Research and development | 17,661 | 14,121 | ||||
Sales and marketing | 8,872 | 8,261 | ||||
General and administrative | 26,060 | 41,478 | ||||
Acquisition related costs | 426 | 1,248 | ||||
Impairment of goodwill and intangibles | 12,199 | 14,789 | ||||
Amortization of intangibles | 5,411 | 4,467 | ||||
Total Operating Expenses | 70,629 | 84,364 | ||||
Loss from Operations | (56,700) | (72,743) | ||||
Other Income (Expense) | ||||||
Interest (expense)/ income, net | (673) | 1,183 | ||||
Loss on exchange of debt for equity | -- | (30) | ||||
Benefit for valuation allowance on related party loan - held for sale | -- | 7,345 | ||||
Other income/(expense) | 692 | (47) | ||||
Gain on related party loan - held for sale | -- | 49,817 | ||||
Unrealized loss on equity securities | (7,904) | (57,067) | ||||
Unrealized loss on equity method investment | (1,784) | -- | ||||
Total Other Income (Expense) | (9,669) | 1,201 | ||||
Net Loss, before tax | (66,369) | (71,542) | ||||
Income tax benefit | 65 | 1,412 | ||||
Net Loss | (66,304) | (70,130) | ||||
Net Loss Attributable to Non-controlling Interest | (2,910) | (975) | ||||
Net Loss Attributable to Stockholders of | $ | (63,394) | $ | (69,155) | ||
Accretion of Series 7 preferred stock | (4,555) | (8,161) | ||||
Accretion of Series 8 Preferred Stock | (13,090) | -- | ||||
Deemed dividend for the modification related to Series 8 Preferred Stock | (2,627) | -- | ||||
Deemed contribution for the modification related to Warrants issued in connection with Series 8 Preferred Stock | 1,469 | -- | ||||
Amortization premium- modification related to Series 8 Prefered Stock | 2,627 | -- | ||||
Net Loss Attributable to Common Stockholders | $ | (79,570) | $ | (77,316) | ||
Net Loss Per Share - Basic and Diluted | $ | (34.12) | $ | (51.18) | ||
Weighted Average Shares Outstanding | ||||||
Basic and Diluted | 2,332,041 | 1,510,678 | ||||
Comprehensive Loss | ||||||
Net Loss | $ | (66,304) | $ | (70,130) | ||
Unrealized foreign exchange gain (loss) from cumulative translation adjustments | 1,017 | (617) | ||||
Comprehensive Loss | $ | (65,287) | $ | (70,747) | ||
INPIXON AND SUBSIDIARIES | ||||||
CONSOLIDATED STATEMENTS OF CASH FLOWS | ||||||
(In thousands) | ||||||
For the Years Ended | ||||||
2022 | 2021 | |||||
Cash Flows Used In Operating Activities | ||||||
Net loss | $ | (66,304) | $ | (70,130) | ||
Adjustments to reconcile net loss to net cash used in operating activities: | ||||||
Depreciation and amortization | 1,374 | 1,344 | ||||
Amortization of intangible assets | 6,082 | 5,107 | ||||
Amortization of right of use asset | 706 | 677 | ||||
Stock options and restricted stock awards granted to employees and consultants for services | 3,656 | 10,879 | ||||
Earnout payment expense | (2,827) | 6,524 | ||||
Loss on exchange of debt for equity | -- | 30 | ||||
Amortization of debt discount | 489 | 224 | ||||
Accrued interest income, related party | (278) | (1,627) | ||||
Provision for doubtful accounts | (32) | 121 | ||||
Unrealized gain/(loss) on note | 1,707 | (92) | ||||
Provision for inventory obsolescense | 10 | 300 | ||||
Recovery for valuation allowance held for sale loan | -- | (7,345) | ||||
Gain on settlement of related party promissory note | -- | (49,817) | ||||
Deferred income tax | (1) | (2,593) | ||||
Unrealized loss on equity securities | 7,904 | 57,067 | ||||
Impairment of goodwill and intangibles | 12,199 | 14,789 | ||||
Loss on disposal of property and equipment | 1 | 24 | ||||
Realized gain on sale of equity securities | 151 | -- | ||||
Unrealized loss on equity method investment | 1,784 | -- | ||||
Gain on conversion of note receivable | (791) | -- | ||||
Other | 211 | 235 | ||||
Changes in operating assets and liabilities: | ||||||
Accounts receivable and other receivables | (115) | (313) | ||||
Inventory | (565) | (112) | ||||
Prepaid expenses and other current assets | 1,375 | (4,006) | ||||
Other assets | 33 | 199 | ||||
Accounts payable | 182 | 391 | ||||
Accrued liabilities | 858 | 490 | ||||
Income tax liabilities | 119 | 16 | ||||
Deferred revenue | (1,214) | 817 | ||||
Operating lease obligation | (677) | (658) | ||||
Other liabilities | -- | 328 | ||||
$ | (33,963) | $ | (37,131) | |||
Cash Flows Used in Investing Activities | ||||||
Purchase of property and equipment | (245) | (346) | ||||
Investment in capitalized software | (948) | (1,019) | ||||
Purchase of short term investments | -- | (2,000) | ||||
Sales of short term investments | -- | 2,000 | ||||
Purchases of treasury bills | -- | (63,362) | ||||
Sales of treasury bills | 43,001 | 28,000 | ||||
Sales of equity securities | 229 | -- | ||||
Purchase of convertible note | (5,500) | -- | ||||
Issuance of note receivable | (150) | -- | ||||
Investment in Systat licensing agreement | -- | (900) | ||||
Purchase of intangible assets | -- | (4) | ||||
Acquisition of Intranav | -- | (1,023) | ||||
Acquisition of Game Your Game | -- | 184 | ||||
Acquisition of CXApp | -- | (14,977) | ||||
Acquisition of Visualix | -- | (61) | ||||
Net Cash Provided by (Used in) Investing Activities | $ | 36,387 | $ | (53,508) | ||
Cash From Financing Activities | ||||||
Net proceeds from issuance of preferred stock and warrants | $ | 46,906 | $ | 50,585 | ||
Net proceeds from issuance of common stock and warrants | -- | 77,852 | ||||
Net proceeds from promissory note | 12,339 | -- | ||||
Taxes paid related to net share settlement of restricted stock units | (336) | (1,855) | ||||
Loans to related party | -- | (117) | ||||
Net proceeds for registered direct offering | 14,088 | -- | ||||
Common shares issued for net proceeds from warrants | 1 | -- | ||||
Cash paid for redemption of preferred stock series 7 | (49,250) | -- | ||||
Cash paid for redemption of preferred stock series 8 | (53,198) | -- | ||||
Repayment of CXApp acquisition liability | (5,136) | (461) | ||||
Repayment of acquisition liability to Nanotron shareholders | -- | (467) | ||||
Repayment of acquisition liability to Locality shareholders | -- | (500) | ||||
$ | (34,586) | $ | 125,037 | |||
Effect of Foreign Exchange Rate on Changes on Cash | (83) | 86 | ||||
Net (Decrease) Increase in Cash and Cash Equivalents | (32,245) | 34,484 | ||||
Cash and Cash Equivalents - Beginning of year | 52,480 | 17,996 | ||||
Cash and Cash Equivalents - End of year | $ | 20,235 | $ | 52,480 | ||
Reconciliation of Non-GAAP Financial Measures: | ||||
For the Years Ended | ||||
(In thousands) | ||||
2022 | 2021 | |||
Net loss attributable to common stockholders | $ (79,570) | $ (77,316) | ||
Interest expense/(income), net | 673 | (1,183) | ||
Income tax benefit | (65) | (1,412) | ||
Depreciation and amortization | 7,456 | 6,451 | ||
EBITDA | (71,506) | (73,460) | ||
Adjusted for: | ||||
Non-recurring one-time charges: | ||||
Loss on exchange of debt for equity | - | 30 | ||
Recovery for valuation allowance on held for sale loan | - | (7,345) | ||
Gain on related party loan held for sale | - | (49,817) | ||
Unrealized loss on equity securities | 7,904 | 57,067 | ||
Unrealized loss on equity method investment | 1,784 | - | ||
Acquisition transaction/financing costs | 426 | 1,248 | ||
Earnout compensation expense | - | 6,524 | ||
Professional service fees | 8 | 1,366 | ||
Accretion of series 7 preferred stock | 4,555 | 8,161 | ||
Accretion of series 8 preferred stock | 13,090 | - | ||
Deemed dividend modification Series 8 preferred stock | 2,627 | - | ||
Deemed contribution modification of warrants | (1,469) | - | ||
Amortization premium modification of Series 8 preferred stock | (2,627) | - | ||
Impairment of goodwill and intangible assets | 12,199 | 14,789 | ||
Unrealized gains on notes and loans | 1,707 | 241 | ||
Bad debts expense/provision | (31) | 121 | ||
Reserve for inventory obsolescence | 1 | 300 | ||
Stock-based compensation – compensation and related benefits | 3,656 | 10,879 | ||
Severance costs | 250 | 294 | ||
Restructuring Costs | 845 | - | ||
Adjusted EBITDA | $ (26,581) | $ (29,602) | ||
For the Years Ended | ||||
(In thousands, except share data) | ||||
2022 | 2021 | |||
Net loss attributable to common stockholders | $ (79,570) | $ (77,316) | ||
Adjustments: | ||||
Non-recurring one-time charges: | ||||
Loss on exchange of debt for equity | - | 30 | ||
Recovery for valuation allowance on held for sale loan | - | (7,345) | ||
Gain on related party loan held for sale | - | (49,817) | ||
Unrealized loss on equity securities | 7,904 | 57,067 | ||
Unrealized loss on equity method investment | 1,784 | - | ||
Acquisition transaction/financing costs | 426 | 1,248 | ||
Earnout compensation expense | - | 6,524 | ||
Professional service fees | 8 | 1,366 | ||
Accretion of series 7 preferred stock | 4,555 | 8,161 | ||
Accretion of series 8 preferred stock | 13,090 | - | ||
Deemed dividend modification Series 8 preferred stock | 2,627 | - | ||
Deemed contribution modification of warrants | (1,469) | - | ||
Amortization premium modification of Series 8 preferred stock | (2,627) | - | ||
Impairment of goodwill and intangible assets | 12,199 | 14,789 | ||
Unrealized gains on notes and loans | 1,707 | 241 | ||
Bad debts expense/provision | (31) | 121 | ||
Reserve for inventory obsolescence | 1 | 300 | ||
Stock-based compensation – compensation and related benefits | 3,656 | 10,879 | ||
Severance costs | 250 | 294 | ||
Restructuring costs | 845 | - | ||
Amortization of intangibles | 6,082 | 5,107 | ||
Proforma non-GAAP net loss | $ (28,563) | $ (28,351) | ||
Proforma non-GAAP net loss per basic and diluted common share | $ (12.25) | $ (18.77) | ||
Weighted average basic and diluted common shares outstanding | 2,332,041 | 1,510,678 | ||
View original content to download multimedia:https://www.prnewswire.com/news-releases/inpixon-reports-2022-financial-results-and-provides-business-update-301786432.html
SOURCE
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Evolution Petroleum launches stock offering to fund Permian Basin deal
- Allied Gold appoints Joanna Pearson to its board of directors
- Enovix names interim CEO after Raj Talluri resignation
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
Twitter, Dividend, Earnings, Definitive AgreementSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share